EAM
APLT

Empery Asset Management’s Applied Therapeutics APLT Stock Holding History

Empery Asset Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-675,000
Closed -$640K – 89
2022
Q2 		$640K Buy
+675,000
New +$1.11M 3.47% 8

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Empery Asset Management's APLT Position: Q3 2022 in Review

Empery Asset Management sold out of Applied Therapeutics (APLT) in Q3 2022, closing a stake of 675,000 shares — an estimated $640K sold.

Empery Asset Management first reported a position in APLT in Q2 2022 and held it in 1 quarter. The position peaked at $640K in Q2 2022. 44 funds tracked by Wall St. Rank hold APLT as of Q3 2022.

  • Empery Asset Management reported no remaining Applied Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Empery Asset Management sold 675,000 Applied Therapeutics shares in Q3 2022, an estimated $640K.
  • Empery Asset Management first reported a position in Applied Therapeutics in Q2 2022 and held it in 1 quarter.
  • Empery Asset Management's Applied Therapeutics position peaked at $640K in Q2 2022.
  • 44 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.